...
首页> 外文期刊>LWT-Food Science & Technology >High iron bioaccessibility from co-microencapsulated iron/ascorbic acid using chelating polypeptides from brewers' spent grain protein as wall material
【24h】

High iron bioaccessibility from co-microencapsulated iron/ascorbic acid using chelating polypeptides from brewers' spent grain protein as wall material

机译:来自共微胶囊/抗坏血酸的高铁生物进一步使用啤酒厂废粒蛋白的螯合多肽作为壁材料

获取原文
获取原文并翻译 | 示例

摘要

Iron fortification is an important and difficult task since most of the bioavailable iron sources are reactive against food matrix. Microencapsulation technology can prevent iron interaction with food matrix. Co-microencapsulation of iron and ascorbic acid was carried out by spray-drying using a protein concentrate obtained from brewers' spent grain (BSG-PC) and locust bean gum as chelating wall materials. Microcapsules were formulated using a 2(2) factorial design. The effect of BSG-PC/wall material (8.6 and 17.2 g protein 100 g(-1)) and ascorbic acid/iron molar ratio (0.9:1 and 1.8:1) on iron encapsulation yield (FeE), ascorbic acid encapsulation (AAE), iron chelated by wall material (FeC), iron bioaccessibility (FeB), particle size, zeta potential, and surface hydrophobicity of the microcapsules were assessed. Higher level of BSG-PC increased FeB at low ascorbic acid/ iron molar ratio due to the high iron-chelating activity of BSG proteins (IC50: 7.9 +/- 1.2 mg mL(-1)). At low levels of BSG-PC, FeB was promoted by ascorbic acid in a dose response way. A multiple response maximization of FeE, AAE, FeB, and FeC was performed and validated. Optimal microcapsule formula resulted with 29% of FeB after simulated gastrointestinal digestion. The optimization procedure allowed obtaining a fortifier with the higher iron bioaccessibility and iron content.
机译:铁强化是一项重要而困难的任务,因为大多数生物可利用的铁源对食物基质都有反应。微胶囊技术可以防止铁与食物基质的相互作用。以啤酒糟(BSG-PC)和刺槐豆胶为螯合壁材,采用喷雾干燥法对铁和抗坏血酸进行共微胶囊化。微胶囊的配方采用2(2)析因设计。研究了BSG-PC/壁材(8.6和17.2 g蛋白质100g(-1))和抗坏血酸/铁摩尔比(0.9:1和1.8:1)对微胶囊铁包封率(FeE)、抗坏血酸包封率(AAE)、壁材螯合铁(FeC)、铁生物可及性(FeB)、粒径、zeta电位和表面疏水性的影响。由于BSG蛋白的高铁螯合活性(IC50:7.9+/-1.2 mg-mL(-1)),在低抗坏血酸/铁摩尔比下,较高水平的BSG-PC增加了FeB。在BSG-PC水平较低时,抗坏血酸以剂量反应方式促进FeB。进行并验证了FeE、AAE、FeB和FeC的多响应最大化。模拟胃肠道消化后,最佳微囊配方的FeB含量为29%。优化程序可获得具有较高铁生物可利用性和铁含量的强化剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号